{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:51:55Z","timestamp":1761663115347},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.diagmicrobio.2012.09.018","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T02:32:16Z","timestamp":1351564336000},"page":"94-100","source":"Crossref","is-referenced-by-count":15,"title":["Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010"],"prefix":"10.1016","volume":"75","author":[{"given":"Chun-Ming","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Chih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0005","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkn073","article-title":"Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance","volume":"61","author":"Asche","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0010","series-title":"Performance standards for antimicrobial susceptibility testing; 18th informational supplement (M100-S19)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0015","series-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard \u2013 ninth edition, M2-A9","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0020","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/dkh163","article-title":"Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram","volume":"53","author":"Cook","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/652154","article-title":"Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals","volume":"31","author":"Eagye","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0030","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/jac\/dkr141","article-title":"Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 year in not associated with the use of ertapenem","volume":"66","author":"Eagye","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0035","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/01.CCM.0000215517.51187.CA","article-title":"Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units","volume":"34","author":"Georges","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jinf.2008.06.001","article-title":"Ertapenem: no effect on aerobic Gram-negative susceptibilities to imipenem","volume":"57","author":"Goff","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0045","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/AAC.00064-09","article-title":"Introduction of ertapenem into a hospital formulary: effect of antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa","volume":"53","author":"Goldstein","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2005.04.007","article-title":"Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents","volume":"26","author":"Hsueh","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijantimicag.2005.08.016","article-title":"Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infection from 1991\u20132003 at a university hospital in Taiwan","volume":"26","author":"Hsueh","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0060","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.00060-06","article-title":"Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa","volume":"50","author":"Kaye","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10096-010-1081-1","article-title":"Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital from 2000 to 2009","volume":"30","author":"Lai","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0070","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/jac\/dkr103","article-title":"Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university in Taiwan from 2000 to 2009","volume":"66","author":"Lai","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijantimicag.2009.11.007","article-title":"Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but no ciprofloxacin use","volume":"35","author":"Lee","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/596781","article-title":"The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study","volume":"30","author":"Lima","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1413-8670(11)70131-3","article-title":"Carbapenem stewardship: positive impact on hospital ecology","volume":"15","author":"Lima","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2334-9-61","article-title":"Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria","volume":"9","author":"Metz-Gercek","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s15010-006-6619-x","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004","volume":"34","author":"Meyer","year":"2006","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/dkh039","article-title":"Antimicrobial usage and resistance trend relationship from MYSTIC programme in North America","volume":"53","author":"Mutnick","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0105","series-title":"Performance standards for antimicrobial susceptibility testing: 13th informational supplement. M100-S13 (M7)","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jac\/dkm510","article-title":"Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome","volume":"61","author":"Nguyen","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0115","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.01535-08","article-title":"Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa","volume":"53","author":"Pakyz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.09.018_bb0120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/528712","article-title":"Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint","volume":"46","author":"Tam","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312003963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312003963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T19:02:10Z","timestamp":1542654130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889312003963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0732889312003963"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.09.018","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}